<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the patient with myalgia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the patient with myalgia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the patient with myalgia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert H Shmerling, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Aronson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karen Law, MD, FACP</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 07, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Myalgia, or muscle pain, is a common complaint among adults presenting for medical care. In fact, nearly everyone will experience muscle soreness at some point in their life. Excessive exertion, trauma, and viral infections are among the most common causes. While many causes are benign and self-limited, myalgia may be the harbinger of disorders associated with significant morbidity.</p><p>A thorough review of the patient's history and a complete physical examination can usually narrow the list of potential causes of myalgia to a manageable few. For persistent or severe myalgia without a known cause, selected testing may be necessary to identify or exclude specific diagnoses and to direct treatment.</p><p>It is important to differentiate myalgia from myopathy (muscle disease) and myositis (muscle inflammation). Although myopathy and myositis may cause myalgia, most individuals with myalgia have neither. It is also useful to separate diffuse from localized symptoms. This review will discuss the approach to myalgia as a presenting symptom to a primary care clinician, focusing on etiology, history, physical examination, laboratory studies, and management. Specific disorders characterized by prominent myalgia are covered elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5625.html" rel="external">"Differential diagnosis of fibromyalgia"</a> and  <a class="medical medical_review" href="/z/d/html/5158.html" rel="external">"Myopathies of systemic disease"</a> and  <a class="medical medical_review" href="/z/d/html/5166.html" rel="external">"Drug-induced myopathies"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Most etiologies of myalgia can be divided based upon diffuse versus focal symptoms, although myalgia may also be multifactorial. For example, a patient may have concomitant rheumatoid arthritis, fibromyalgia, and pes anserinus pain syndrome (formerly anserine bursitis). (See  <a class="medical medical_review" href="/z/d/html/7759.html" rel="external">"Knee bursitis"</a> and  <a class="medical medical_review" href="/z/d/html/7757.html" rel="external">"Overview of soft tissue musculoskeletal disorders", section on 'Myofascial pain syndrome'</a> and  <a class="medical medical_review" href="/z/d/html/7502.html" rel="external">"Clinical manifestations of rheumatoid arthritis"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Diffuse myalgias</span><span class="headingEndMark"> — </span>The most common causes of diffuse myalgia are  (<a class="graphic graphic_table graphicRef60716" href="/z/d/graphic/60716.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic infection, including viral, bacterial, and spirochetal diseases [<a href="#rid1">1-6</a>]. As a prominent example, dengue fever is sometimes called "break bone fever" due to the severe muscle and joint pain associated with this virus. Prominent myalgia is also a typical feature of influenza [<a href="#rid7">7</a>] and coronavirus disease 2019 (COVID-19) [<a href="#rid8">8</a>]. Moreover, myalgia at the time of hospital admission for COVID-19 may be associated with persistent post-COVID musculoskeletal pain [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1">In addition, vaccination may also cause significant, though short-lived, myalgia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rheumatic disease, especially polymyalgia rheumatica (PMR), inflammatory myopathy [<a href="#rid10">10,11</a>], or autoinflammatory disease [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/8235.html" rel="external">"Clinical manifestations and diagnosis of polymyalgia rheumatica"</a> and  <a class="medical medical_review" href="/z/d/html/5159.html" rel="external">"Clinical manifestations of dermatomyositis and polymyositis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noninflammatory conditions, such as fibromyalgia and chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/z/d/html/5625.html" rel="external">"Differential diagnosis of fibromyalgia"</a> and  <a class="medical medical_review" href="/z/d/html/2740.html" rel="external">"Clinical features and diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medications, particularly the use of statins (with or without creatine kinase elevation) [<a href="#rid14">14,15</a>], <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">ciprofloxacin</a> [<a href="#rid16">16</a>], bisphosphonates [<a href="#rid17">17</a>], aromatase inhibitors [<a href="#rid18">18,19</a>], or withdrawal from antidepressant therapy [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/5166.html" rel="external">"Drug-induced myopathies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic disorders, such as mitochondrial myopathy [<a href="#rid21">21,22</a>], vitamin D deficiency [<a href="#rid23">23,24</a>], and scurvy [<a href="#rid25">25</a>], can lead to myalgias, although these are rarer causes. (See  <a class="medical medical_review" href="/z/d/html/6193.html" rel="external">"Approach to the metabolic myopathies"</a> and  <a class="medical medical_review" href="/z/d/html/5151.html" rel="external">"Mitochondrial myopathies: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Liver disease, such as chronic viral hepatitis and autoimmune hepatitis [<a href="#rid1">1,2,26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endocrine disorders, such as thyroid disease [<a href="#rid27">27,28</a>] and adrenal insufficiency [<a href="#rid29">29</a>] can lead to myopathic pain. Of note, glucocorticoid-induced myopathy often leads to muscle weakness and wasting without pain. (See  <a class="medical medical_review" href="/z/d/html/4837.html" rel="external">"Hypothyroid myopathy"</a> and  <a class="medical medical_review" href="/z/d/html/5171.html" rel="external">"Glucocorticoid-induced myopathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Psychiatric, as with somatic manifestations of depression [<a href="#rid30">30,31</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Localized myalgia</span><span class="headingEndMark"> — </span>The most common causes of localized myalgia are  (<a class="graphic graphic_table graphicRef61398" href="/z/d/graphic/61398.html" rel="external">table 2</a>) [<a href="#rid32">32-36</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Overuse or strenuous exercise</p><p class="bulletIndent1"><span class="glyph">●</span>Soft tissue disease (such as bursitis, trauma, or infection)</p><p class="bulletIndent1"><span class="glyph">●</span>Pyomyositis</p><p class="bulletIndent1"><span class="glyph">●</span>Myofascial pain syndrome</p><p class="bulletIndent1"><span class="glyph">●</span>Muscle infarction or compartment syndrome</p><p></p><p class="headingAnchor" id="H5"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>For patients presenting with myalgia, it is common that the diagnosis cannot be established at the initial visit. This may relate in part to the need to follow symptoms over time and to obtain laboratory or other diagnostic studies. In fact, the course of symptoms and signs over time may be particularly helpful. (See <a class="local">'Muscle symptoms'</a> below.)</p><p>The list of conditions associated with myalgia is long  (<a class="graphic graphic_table graphicRef60716" href="/z/d/graphic/60716.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef61398" href="/z/d/graphic/61398.html" rel="external">table 2</a>). In patients with a characteristic pattern of symptoms, the diagnosis may be established promptly. However, considerable uncertainty is common after initial evaluation. Selective testing and vigilant follow-up may be necessary for several months to narrow the list of potential explanations.</p><p class="headingAnchor" id="H6"><span class="h2">Serious conditions</span><span class="headingEndMark"> — </span>Early in the evaluation of patients with myalgia, the clinician should attempt to identify those patients with a serious or life-threatening condition. Conditions causing myalgia may cause significant suffering, but true medical emergencies presenting with myalgia are rare. Prompt diagnosis and treatment are required for bacterial infections, especially endocarditis and impending sepsis, which may present with diffuse myalgia, fever, chills, arthralgia, fatigue and back pain [<a href="#rid4">4</a>]. Rhabdomyolysis with renal failure may complicate a number of myalgic conditions, including crush injury or compression, exertion, hyperthermia, toxins, or systemic infection. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/5169.html" rel="external">"Rhabdomyolysis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">History</span><span class="headingEndMark"> — </span>The patient's history provides a useful starting point in narrowing down the long list of potential causes for myalgia. Particular attention should be given to mode of onset, location of pain, and associated symptoms.</p><p class="headingAnchor" id="H8"><span class="h3">Muscle symptoms</span><span class="headingEndMark"> — </span>The first step in determining the cause of myalgia is to inquire about the specific nature of the patient's muscle pain:</p><p class="bulletIndent1"><span class="glyph">●</span>Did the muscle pain begin suddenly or gradually? If sudden in onset, did it follow trauma or an unusually strenuous activity? Is the muscle pain worse in the morning?</p><p></p><p class="bulletIndent1">As an example, acute onset with prominent constitutional symptoms suggests infection (such as bacterial sepsis, pyomyositis, influenza or acute hepatitis B). Acute onset of myalgia in the neck, shoulders, upper arms, buttocks, and thighs in an older adult is characteristic of polymyalgia rheumatica (PMR), especially if accompanied by morning stiffness.</p><p></p><p class="bulletIndent1">Subacute myalgia is typical of a medication-induced cause (such as statin-induced myalgia) and can occur weeks to months after initiating therapy. (See  <a class="medical medical_review" href="/z/d/html/6833.html" rel="external">"Statin muscle-related adverse events", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1">Insidious onset and chronic symptoms are typical of infection with chronic hepatitis C, hypothyroidism, hypercalcemia, and vitamin D deficiency. This is also the typical pattern for patients with fibromyalgia, chronic fatigue syndrome (CFS), myofascial pain syndrome, and a somatization disorder.</p><p></p><p class="bulletIndent1">In addition, muscle pain and stiffness in the morning is highly suggestive of PMR or other inflammatory arthritis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is the muscle pain associated with pain elsewhere? Is it near joints? If so, are they axial joints, such as the shoulder and hips? Shoulder and hip pathology, in particular, tend to cause referred pain to proximal muscles. Referred pain accounts for the prominent myalgia described by patients with PMR and rheumatoid arthritis involving the shoulders.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is there a particular distribution of muscle pain? Statin-induced myalgia typically presents as proximal, symmetric muscle weakness and soreness. By contrast, diffuse myalgia, fever, headache, malaise, and a nonproductive cough are typical of a viral infection, such as influenza. (See  <a class="medical medical_review" href="/z/d/html/6833.html" rel="external">"Statin muscle-related adverse events"</a> and  <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is there redness, swelling, or warmth in the area of the muscle pain? Is the muscle painful to touch? Pyomyositis, abscess, muscle infarction, or compartment syndrome may cause focal muscle tenderness. Pyomyositis and abscess may cause localized inflammatory findings as well.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is the myalgia associated with muscle weakness? Is it difficult to arise from a chair or reach above the head? Objective muscle weakness is not expected with fibromyalgia, myofascial pain syndrome, or PMR; these common causes of muscle pain can be placed lower on the list of possibilities in the face of demonstrable muscle weakness. (See  <a class="medical medical_review" href="/z/d/html/5155.html" rel="external">"Approach to the patient with muscle weakness"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have there been muscle cramps? The etiology of muscle cramps is often not found, but they can be caused by several conditions:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Structural disorders such as flat feet</p><p class="bulletIndent2"><span class="glyph">•</span>Unusual positioning during work or sleep</p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic disorders such as Parkinson disease</p><p class="bulletIndent2"><span class="glyph">•</span>Muscle injury such as trauma or fall</p><p class="bulletIndent2"><span class="glyph">•</span>Dehydration</p><p class="bulletIndent2"><span class="glyph">•</span>Exercise-associated muscle cramping or spasm</p><p class="bulletIndent2"><span class="glyph">•</span>Electrolyte abnormalities</p><p class="bulletIndent2"><span class="glyph">•</span>Medications such as diuretics, statins, and beta agonists.</p><p></p><p>Leg cramps occurring at night are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5177.html" rel="external">"Nocturnal leg cramps"</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Associated symptoms</span><span class="headingEndMark"> — </span>The presence or absence of associated symptoms can be quite helpful in pointing toward or against a particular cause. The clinician should undertake a detailed review of systems with particular attention paid to:</p><p class="bulletIndent1"><span class="glyph">●</span>Constipation</p><p class="bulletIndent1"><span class="glyph">●</span>Depression</p><p class="bulletIndent1"><span class="glyph">●</span>Fatigue</p><p class="bulletIndent1"><span class="glyph">●</span>Fever</p><p class="bulletIndent1"><span class="glyph">●</span>Joint pain or swelling</p><p class="bulletIndent1"><span class="glyph">●</span>Paresthesias</p><p class="bulletIndent1"><span class="glyph">●</span>Rash or hyperpigmentation</p><p class="bulletIndent1"><span class="glyph">●</span>Weight change</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea, vomiting or diarrhea</p><p></p><p>Constipation, fatigue, and weight gain are common symptoms of hypothyroidism, whereas rash or hyperpigmentation are suggestive of infection or adrenal insufficiency, respectively. Fever raises the possibility of infection or systemic rheumatic disease (such as systemic lupus erythematosus) or autoinflammatory disease (such as familial Mediterranean fever) while joint swelling suggests inflammatory arthritis. Paresthesias suggest a neuropathic condition, which may cause myalgia due to referred pain or indicate the presence of a vasculitic process.</p><p class="headingAnchor" id="H10"><span class="h3">Other history</span><span class="headingEndMark"> — </span>The cause of myalgia may not be apparent until additional details of the patient's medical history are considered. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Patient demographics, such as age and sex. For example, newly diagnosed systemic lupus erythematosus and rheumatoid arthritis are most common among young adult women, while PMR is seen exclusively among adults over the age of 55.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Past medical history, such as a prior diagnosis of thyroid disease, hepatitis C, diabetes, or hyperparathyroidism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recent exposure to individuals who have symptoms suggestive of influenza, COVID-19, or other viral illness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medication use, especially statin administration, can lead to myalgias.</p><p></p><p class="bulletIndent1">Myalgia due to statin or fibrate medications may be associated with weakness and an elevation in creatine kinase, but these features are often absent [<a href="#rid37">37</a>]. Drug interactions account for many cases of medication-induced myalgia or myopathy, particularly in patients taking statins and inhibitors of CYP3A4  (<a class="graphic graphic_table graphicRef76992" href="/z/d/graphic/76992.html" rel="external">table 3</a>). A number of other common medications may be associated with myalgia, including bisphosphonates and aromatase inhibitors.</p><p></p><p class="bulletIndent1">In addition, abrupt discontinuation of serotonin-reuptake inhibitors with short half-lives (such as <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">venlafaxine</a> or <a class="drug drug_general" data-topicid="9743" href="/z/d/drug information/9743.html" rel="external">paroxetine</a>) may cause significant myalgia [<a href="#rid30">30,31</a>]. Muscle symptoms that follow the administration of a new medication should prompt the clinician to consider drug-induced muscle pain. (See  <a class="medical medical_review" href="/z/d/html/6833.html" rel="external">"Statin muscle-related adverse events"</a> and  <a class="medical medical_review" href="/z/d/html/5166.html" rel="external">"Drug-induced myopathies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trauma, a change in activity or function, recent injury, or unusually strenuous exercise may trigger muscle pain, which is typically localized.</p><p></p><p class="bulletIndent1">Understanding the functional status of the patient or a recent change in function can help determine the pace and direction of the evaluation. For example, the possibility of myopathy is raised by a patient with myalgia who has difficulty arising from a chair or with activities of daily living. For individuals with longstanding myalgia without alteration in function, fibromyalgia [<a href="#rid38">38</a>] should be a prime consideration. (See  <a class="medical medical_review" href="/z/d/html/5624.html" rel="external">"Clinical manifestations and diagnosis of fibromyalgia in adults", section on 'Diagnostic evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/5625.html" rel="external">"Differential diagnosis of fibromyalgia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A psychologic assessment may aid in the diagnosis of depression or a somatization disorder as a cause of myalgia.</p><p></p><p class="headingAnchor" id="H11"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>While the history can provide important clues to the cause of myalgia, the physical examination can provide compelling, objective evidence for myopathy (muscle disease) or an alternative explanation for the symptoms.</p><p class="headingAnchor" id="H12"><span class="h3">Muscle examination</span><span class="headingEndMark"> — </span>Although it can be difficult for a patient with myalgia to cooperate fully with a muscle examination, the finding of weakness can be particularly helpful in narrowing down the list of possible causes of symptoms by excluding many. For example, the finding of proximal muscle weakness in all four extremities in a patient with myalgia should turn the focus of diagnostic considerations to inflammatory myopathy (such as polymyositis), hypothyroidism, drug-induced myopathy, or hypercalcemia. Identifying objective weakness is important because weakness (with or without myalgia) is a common complaint even in the absence of demonstrable loss of motor function.</p><p>Even patients with significant pain can usually give maximum effort at least briefly to provide the examiner with a sense of whether muscle strength is normal. Besides assessing muscle strength in the usual proximal and distal muscle groups (including deltoids, wrist extensors, grip, thigh flexors, and ankle flexors and extensors), assessment of neck flexor strength may be useful as these muscles are a powerful and often overlooked proximal muscle group.</p><p>Besides the assessment of weakness, helpful findings on muscle examination may include focal swelling or erythema, which should raise the possibility of pyomyositis or other localized infection. Severe, localized tenderness without inflammatory features suggests muscle infarction or compartment syndrome. (See  <a class="medical medical_review" href="/z/d/html/5135.html" rel="external">"Diabetic muscle infarction"</a> and  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities"</a>.)</p><p>It should be noted that muscle weakness without pain includes a much broader differential diagnosis discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5155.html" rel="external">"Approach to the patient with muscle weakness"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">General physical examination</span><span class="headingEndMark"> — </span>The source of myalgia may lie far from the muscles. For this reason, as well as the fact that diseases causing myalgia may affect other organ systems, a thorough physical examination should follow, with particular attention to the presence of the following physical findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever (which may suggest viral infection, pyomyositis, endocarditis, or impending sepsis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypotension (as may be found in patients with sepsis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperpigmentation and postural hypotension (as may be present in adrenal insufficiency). (See  <a class="medical medical_review" href="/z/d/html/159.html" rel="external">"Clinical manifestations of adrenal insufficiency in adults", section on 'Musculoskeletal'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cutaneous lesions (such as those found in systemic lupus erythematosus, vasculitis, Lyme disease, psoriasis, or endocarditis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ecchymoses (suggestive of recent trauma).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Limited shoulder and hip range of motion (consistent with PMR) or spinal disease (as may be noted in patients with spondyloarthropathy).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Joint inflammation (swelling, heat, warmth, and/or limited motion) in the peripheral joints (as is typical of rheumatoid arthritis, psoriatic arthritis, or systemic lupus erythematosus).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bursal or tendon tenderness with more limitation of active motion than passive motion (compatible with bursitis or tendonitis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tender points (as with fibromyalgia) or trigger points (suggestive of myofascial pain syndrome), although the ability to distinguish tender and trigger points is controversial. While the presence of multiple tender points in characteristic locations is highly suggestive of fibromyalgia, their absence does not exclude the diagnosis  (<a class="graphic graphic_figure graphicRef120690" href="/z/d/graphic/120690.html" rel="external">figure 1</a>). The clinical manifestations and diagnosis of fibromyalgia are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5625.html" rel="external">"Differential diagnosis of fibromyalgia", section on 'Myofascial pain syndromes'</a> and  <a class="medical medical_review" href="/z/d/html/5624.html" rel="external">"Clinical manifestations and diagnosis of fibromyalgia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe, focal muscle pain should suggest the possibility of muscle infarction, compartment syndrome, or pyomyositis. (See  <a class="medical medical_review" href="/z/d/html/5135.html" rel="external">"Diabetic muscle infarction", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/7669.html" rel="external">"Primary pyomyositis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Delayed relaxation of reflexes, slowed speech, dry skin, hoarse voice, or other signs of hypothyroidism. (See  <a class="medical medical_review" href="/z/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism", section on 'Musculoskeletal symptoms'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Depressed or flattened affect (as an indication of depression or as associated with a somatization disorder).</p><p></p><p class="headingAnchor" id="H14"><span class="h2">Laboratory studies</span><span class="headingEndMark"> — </span>For mild symptoms, watchful waiting without laboratory evaluation may be appropriate, as symptoms often resolve on their own with time. However, for more significant symptoms (eg, severe pain or muscle weakness), selected laboratory studies may be quite helpful in ruling in or ruling out conditions that remain in the differential diagnosis after a detailed history and physical examination.</p><p>As an initial assessment, complete blood count, urinalysis, and measures of renal and liver function are appropriate for most patients with significant myalgia. Depending upon the specific symptoms, risk factors and physical findings, measures of serum calcium, albumin, phosphate, TSH, creatine kinase, and 25-hydroxyvitamin D may be appropriate to assess, especially if symptoms are prominent, persistent, and otherwise unexplained. Weakness should prompt creatine kinase measurement while bone pain and/or abnormal measures of serum calcium make it important to test for hypovitaminosis D. Cold intolerance, fatigue, and delayed reflexes may suggest hypothyroidism as a cause of myalgia.</p><p>The following tests may also prove helpful in certain clinical situations  (<a class="graphic graphic_table graphicRef60716" href="/z/d/graphic/60716.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Blood cultures and serologic testing for viral infections (such as parvovirus and viral hepatitis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) – These may be helpful to identify the presence of systemic inflammation, as with infection and systemic rheumatic disease (especially PMR and inflammatory myopathy). On the other hand, a normal ESR is the expected finding in patients with fibromyalgia.</p><p></p><p class="bulletIndent1">However, caution must be taken in interpreting these test results as elevations in the ESR and CRP are not specific. In addition, normal or unimpressive results rarely rule out a particular cause of myalgia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Autoantibodies, such as antinuclear antibodies (ANA) for suspected systemic lupus erythematosus, anti-neutrophilic cytoplasmic antibodies (ANCA) for suspected ANCA-associated vasculitis, as well as rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies for suspected rheumatoid arthritis, should be limited to those patients for whom there is at least a moderate pre-test probability of disease. Widespread testing with these autoantibody tests for all patients with myalgia is likely to produce an unacceptably high rate of false-positive results. (See  <a class="medical medical_review" href="/z/d/html/1822.html" rel="external">"Measurement and clinical significance of antinuclear antibodies"</a> and  <a class="medical medical_review" href="/z/d/html/7503.html" rel="external">"Biologic markers in the assessment of rheumatoid arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Testing of cortisol production, such as morning serum cortisol or adrenocorticotropic hormone (ACTH) stimulation test, are helpful to diagnose or rule out adrenal insufficiency. (See  <a class="medical medical_review" href="/z/d/html/154.html" rel="external">"Determining the etiology of adrenal insufficiency in adults"</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h2">Other studies</span></p><p class="bulletIndent1"><span class="glyph">●</span>Imaging – Radiographs, magnetic resonance imaging (MRI), and other imaging tests are not routinely necessary in the evaluation of myalgia. Utility is limited to assessment of erosive arthritis (rheumatoid arthritis and others), fracture, inflammatory muscle disease, or localized muscle disease (pyomyositis, muscle infarction).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurophysiology studies – Electromyogram (EMG) with nerve conduction studies (NCS) may be helpful to support the diagnosis of inflammatory or metabolic myopathy, as well as a neuropathic process. (See  <a class="medical medical_review" href="/z/d/html/5145.html" rel="external">"Overview of electromyography", section on 'Diagnostic electromyography'</a> and  <a class="medical medical_review" href="/z/d/html/127066.html" rel="external">"Overview of and approach to the idiopathic inflammatory myopathies", section on 'Electromyography'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tissue sampling (eg, aspiration or biopsy) – Most patients with myalgia will not require tissue sampling. However, it may be diagnostic for patients with suspected abscess, inflammatory myopathy, vasculitis, or systemic lupus erythematosus.</p><p></p><p class="headingAnchor" id="H16"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>There are no established guidelines or expert consensus regarding how best to treat myalgia. Features of the history, physical examination, and selective testing may prove particularly useful to identify the etiology that will guide management.</p><p>If medication-induced myalgia is suspected, a trial off the medication is warranted, though only after balancing the clinical improvement gained from such a trial with the risks of stopping the drug. It may take weeks or even months, however, to get a clear sense of whether myalgia was related to a medication [<a href="#rid39">39</a>]. A notable exception is polymyalgia rheumatica (PMR), a condition in which a rapid and dramatic improvement within a few days of low-dose corticosteroid treatment is typical. In fact, this prompt response to treatment can help confirm the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/8222.html" rel="external">"Treatment of polymyalgia rheumatica", section on 'Initial dose'</a>.)</p><p>When the cause of myalgia cannot be readily identified, patients should be closely observed and treated symptomatically if needed. In the absence of specific contraindications, treatment may include heat, rest, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, nonsteroidal antiinflammatory drugs (NSAIDs), and/or muscle relaxants.</p><p>Indications for referral include suspicion of a particular condition for which specialty care is warranted (such as referral to a rheumatologist for suspected PMR) or severe, functionally limiting symptoms, especially if they are worsening or persistent.</p><p class="headingAnchor" id="H21901844"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17181.html" rel="external">"Patient education: Nocturnal (nighttime) leg cramps (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies: Diffuse versus localized myalgia</strong> – The etiology of myalgia can be divided into conditions causing diffuse or localized symptoms  (<a class="graphic graphic_table graphicRef60716" href="/z/d/graphic/60716.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef61398" href="/z/d/graphic/61398.html" rel="external">table 2</a>). Conditions leading to diffuse myalgias include systemic rheumatic disease, fibromyalgia, infection, medication use, metabolic derangements, hypothyroidism, and psychiatric causes. Conditions leading to localized myalgia include strenuous activity, soft tissue disease, pyomyositis, myofascial pain syndrome, muscle infarction, and compartment syndrome. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluate for potentially life-threatening conditions</strong> – Prompt diagnosis and treatment are required for bacterial infections, especially endocarditis and impending sepsis, which may present with diffuse myalgia as well as fever, chills, and arthralgia. Rhabdomyolysis can present with diffuse myalgias, as well as renal failure and/or compartment syndrome in severe cases. (See <a class="local">'Serious conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment</strong> – The clinical history should include mode of onset, location of pain, muscle weakness, associated symptoms, medication use, and any previous trauma. The physical examination should include an assessment of focal muscle pain or inflammation, muscle weakness, and examination of findings associated with other medical conditions. (See <a class="local">'History'</a> above and <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory evaluation</strong> – For mild symptoms, watchful waiting without laboratory evaluation may be appropriate, as symptoms often resolve on their own. However, for more significant symptoms including severe pain or muscle weakness, selected laboratory studies may be quite helpful in ruling in or ruling out disease. As an initial assessment, a complete blood count, urinalysis, and measures of renal and liver function are appropriate for most patients with significant myalgia. Other specific testing will depend on the history and physical examination findings. (See <a class="local">'Laboratory studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Management of myalgia usually depends on the underlying cause. When the cause cannot be readily identified, patients should be closely observed and treated symptomatically. In the absence of specific contraindications, empiric treatment may include heat, rest, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, nonsteroidal antiinflammatory drugs (NSAIDs), and/or muscle relaxants. (See <a class="local">'Management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 2006; 73:633.</a></li><li><a class="nounderline abstract_t">Archard LC, Bowles NE, Behan PO, et al. Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med 1988; 81:326.</a></li><li><a class="nounderline abstract_t">Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc 2008; 83:566.</a></li><li><a class="nounderline abstract_t">González-Juanatey C, González-Gay MA, Llorca J, et al. Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study. Medicine (Baltimore) 2001; 80:9.</a></li><li><a class="nounderline abstract_t">Misra UK, Kalita J, Maurya PK, et al. Dengue-associated transient muscle dysfunction: clinical, electromyography and histopathological changes. Infection 2012; 40:125.</a></li><li><a class="nounderline abstract_t">Reau N, Vekeman F, Wu E, et al. Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy. Hepatol Commun 2017; 1:439.</a></li><li><a class="nounderline abstract_t">Pedersen CJ, Quinn JV, Rogan DT, Yang S. Factors Associated With Influenza in an Emergency Department Setting. J Emerg Med 2019; 56:478.</a></li><li><a class="nounderline abstract_t">Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci 2020; 41:3039.</a></li><li><a class="nounderline abstract_t">Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Fuensalida-Novo S, et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain 2021; 162:2832.</a></li><li><a class="nounderline abstract_t">Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372:234.</a></li><li><a class="nounderline abstract_t">Pease CT, Haugeberg G, Morgan AW, et al. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation. J Rheumatol 2005; 32:1043.</a></li><li><a class="nounderline abstract_t">Caso F, Rigante D, Vitale A, et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol 2013; 2013:513782.</a></li><li><a class="nounderline abstract_t">Meeus M, Nijs J, Meirleir KD. Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review. Eur J Pain 2007; 11:377.</a></li><li><a class="nounderline abstract_t">Siddiqi SA, Thompson PD. How do you treat patients with myalgia who take statins? Curr Atheroscler Rep 2009; 11:9.</a></li><li><a class="nounderline abstract_t">Jacobson TA. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia. Mayo Clin Proc 2008; 83:687.</a></li><li><a class="nounderline abstract_t">Eisele S, Garbe E, Zeitz M, et al. Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature. Int J Clin Pharmacol Ther 2009; 47:165.</a></li><li><a class="nounderline abstract_t">Lambrinoudaki I, Vlachou S, Galapi F, et al. Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. Clin Interv Aging 2008; 3:445.</a></li><li><a class="nounderline abstract_t">Yamamoto Y, Iwase H. Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer. Int J Clin Oncol 2008; 13:384.</a></li><li><a class="nounderline abstract_t">Conte P, Frassoldati A. Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective. Breast J 2007; 13:28.</a></li><li><a class="nounderline abstract_t">Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997; 58 Suppl 7:37.</a></li><li><a class="nounderline abstract_t">Testa M, Navazio FM, Neugebauer J. Recognition, diagnosis, and treatment of mitochondrial myopathies in endurance athletes. Curr Sports Med Rep 2005; 4:282.</a></li><li><a class="nounderline abstract_t">DiMauro S, Gurgel-Giannetti J. The expanding phenotype of mitochondrial myopathy. Curr Opin Neurol 2005; 18:538.</a></li><li><a class="nounderline abstract_t">Lyman D. Undiagnosed vitamin D deficiency in the hospitalized patient. Am Fam Physician 2005; 71:299.</a></li><li><a class="nounderline abstract_t">Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463.</a></li><li><a class="nounderline abstract_t">Fain O. Musculoskeletal manifestations of scurvy. Joint Bone Spine 2005; 72:124.</a></li><li><a class="nounderline abstract_t">Muratori P, Granito A, Pappas G, et al. Autoimmune liver disease 2007. Mol Aspects Med 2008; 29:96.</a></li><li><a class="nounderline abstract_t">Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004; 71:275.</a></li><li><a class="nounderline abstract_t">Bazzichi L, Rossi A, Giuliano T, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 2007; 26:2115.</a></li><li><a class="nounderline abstract_t">Shapiro MS, Trebich C, Shilo L, Shenkman L. Myalgias and muscle contractures as the presenting signs of Addison's disease. Postgrad Med J 1988; 64:222.</a></li><li><a class="nounderline abstract_t">Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology 2000; 33:307.</a></li><li><a class="nounderline abstract_t">Vaccarino AL, Sills TL, Evans KR, Kalali AH. Multiple pain complaints in patients with major depressive disorder. Psychosom Med 2009; 71:159.</a></li><li><a class="nounderline abstract_t">Alvarez-Nemegyei J, Canoso JJ. Evidence-Based Soft Tissue Rheumatology IV: Anserine Bursitis. J Clin Rheumatol 2004; 10:205.</a></li><li><a class="nounderline abstract_t">Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis tropicans): current perspective. Postgrad Med J 2004; 80:267.</a></li><li><a class="nounderline abstract_t">Bennett R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol 2007; 21:427.</a></li><li><a class="nounderline abstract_t">Naderi AS, Farsian FN, Palmer BF. Diabetic muscle necrosis. J Diabetes Complications 2008; 22:150.</a></li><li><a class="nounderline abstract_t">Buell KG, Ajmal SR. Diabetic Myonecrosis: A Poorly Recognized Complication in an Adult With Type 2 Diabetes. Can J Diabetes 2020; 44:213.</a></li><li><a class="nounderline abstract_t">Mammen AL, Amato AA. Statin myopathy: a review of recent progress. Curr Opin Rheumatol 2010; 22:644.</a></li><li><a class="nounderline abstract_t">Arnold LM, Bennett RM, Crofford LJ, et al. AAPT Diagnostic Criteria for Fibromyalgia. J Pain 2019; 20:611.</a></li><li><a class="nounderline abstract_t">Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med 2011; 78:393.</a></li></ol></div><div id="topicVersionRevision">Topic 2751 Version 39.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17056293" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Rheumatologic manifestations of chronic hepatitis C infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3404526" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18452688" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Diagnosis and treatment of Lyme disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11204504" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22005935" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Dengue-associated transient muscle dysfunction: clinical, electromyography and histopathological changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29404471" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30803847" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Factors Associated With Influenza in an Emergency Department Setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32935156" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Neuromuscular presentations in patients with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33863864" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18640460" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Polymyalgia rheumatica and giant-cell arteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15940765" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24282415" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16843021" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19080722" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : How do you treat patients with myalgia who take statins?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18533086" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19281725" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18982915" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18946748" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17214790" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9219493" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical management of antidepressant discontinuation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16144587" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Recognition, diagnosis, and treatment of mitochondrial myopathies in endurance athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16155436" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The expanding phenotype of mitochondrial myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15686300" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Undiagnosed vitamin D deficiency in the hospitalized patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14661675" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15797491" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Musculoskeletal manifestations of scurvy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18067956" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Autoimmune liver disease 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15288851" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Chronic autoimmune thyroiditis and rheumatic manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17487449" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association between thyroid autoimmunity and fibromyalgic disease severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2845381" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Myalgias and muscle contractures as the presenting signs of Addison's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11060514" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pain complaints in depressed inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19073755" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Multiple pain complaints in patients with major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17043509" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Evidence-Based Soft Tissue Rheumatology IV: Anserine Bursitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15138315" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Tropical pyomyositis (myositis tropicans): current perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17602992" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Myofascial pain syndromes and their evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18280448" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Diabetic muscle necrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31474461" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diabetic Myonecrosis: A Poorly Recognized Complication in an Adult With Type 2 Diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20827205" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Statin myopathy: a review of recent progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30453109" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : AAPT Diagnostic Criteria for Fibromyalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21632911" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Statin myopathy: a common dilemma not reflected in clinical trials.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
